GHO CAPITAL PARTNERS - Key Persons
Job Titles:
- Founder
- Managing Partner
- Member of the Board at Alcami
Alan has over 30 years private equity investment experience, with a strong track record of dedicated healthcare investing.
Previously, Alan was a board member at 3i plc, led the build-out of the 3i Europe office network, and founded 3i's healthcare sector team as Global Head of Healthcare. Subsequently, Alan was founder, CEO and Chairman of the Investment Committee at Hermes GPE, an active co-investor in private equity-backed healthcare.
Alan is currently a member of the board at Alcami, RoslinCT, X-Chem, Ardena, Sterling, Linimed and Alcaliber and previously Quotient Sciences until its successful exit.
Alan holds a Bachelor's degree in Law, an MSc in Enterprise and is a graduate of the Advanced Management Programme at INSEAD. Originally from Scotland, Alan has worked and lived across continental Europe as well as leading deals in North America. He was Chair of the BVCA and for a number of years chaired the BVCA Responsible Investment Advisory Board, and is currently Chairman of the European Healthcare Private Equity Association (eHCPEA).
Alessandra is an investment professional with a background in banking.
Alessandra joined the GHO team in 2022 and currently works closely with the FairJourney Biologics team.
Before joining GHO, Alessandra worked in the Principal Investments Team at Investec Bank Plc where she was responsible for evaluating and executing entrepreneur-led deals in addition to portfolio management across a diverse range of industries. Prior to that, she worked at Investec Bank Limited where she spent three years working across various business units with a focus on alternative asset classes..
Alessandra graduated with distinction from the University of Cape Town with a Post-Graduate Diploma in Accounting and a Business Science Degree specialising in Finance and Accounting and is a Chartered Accountant. In 2021, she obtained her CFA Charterholder.
Alison is an experienced corporate lawyer with a background in M&A advisory work.
Having joined GHO in 2020, Alison heads up the legal and compliance function at GHO and works on the fund structuring and legal M&A aspects of the investment function.
Prior to GHO, Alison worked in the corporate M&A team at Clifford Chance, where she gained a wealth of transaction experience advising corporates (public and private) and financial sponsors on M&A and corporate advisory matters.
Alison graduated from University College Cork with a first class degree in Law. As part of her studies, Alison spent a year studying at the Beasley School of Law, Temple University in Philadelphia. She has worked and studied in multiple jurisdictions, including periods spent in Hong Kong, Amsterdam and the US.
Andrea brings over 30 years' experience supporting healthcare entrepreneurs, founders, managers and boards develop and grow their businesses globally.
The founder of dedicated European healthcare investment banking franchises at both JP Morgan and Goldman Sachs, Andrea has advised on some of the most significant M&A transactions across leading pharmaceutical, medical device and hospital companies both in Europe and globally. With responsibilities including Vice Chairman of European Investment Banking at JP Morgan and Partner, Managing Director, Head of European Healthcare at Goldman Sachs, Andrea has developed a unique network spanning the entire healthcare value chain and a track record of supporting successful management teams to achieve their growth ambitions through debt and equity financing as well as transactional expertise.
Andrea is currently on the boards of RoslinCT, Envision Pharma Group, FairJourney Biologics, Sterling Pharma, and VISUfarma and has overseen successful exits for Caprion Biosciences.
Originally from Italy and holding a BA in Economics with Highest Honours from the University of North Carolina at Chapel Hill, Andrea has lived and worked across the USA, UK and continental Europe. Andrea helped found a Blueprint for Better Business to help corporates be guided and inspired by a purpose that benefits society.
Having joined GHO in 2021, Azim works closely with GHOs administrators, tax advisors and other service providers, with a focus on fund accounting and portfolio management.
Prior to joining GHO, Azim was an Audit Assistant Manager within the Asset Management team at BDO, where he was responsible for the management of a portfolio of Private Equity clients. Starting his audit career as a generalist, he later specialised in the Financial Services sector specialising on Venture Capital Trusts and Asset Managers. Azim has worked and lived in Sydney, Australia where he worked on Healthcare, FinTech and US listed clients.
Azim graduated from the University of Manchester and holds a Bachelor of Science in Accounting and is a Qualified Chartered Accountant.
Brad is an investment profesional with a background in corporate finance and experience investing across a broad range of industries.
Having joined GHO in 2022, Brad currently works with the management teams at Genesis Research and ClearView Healthcare Partners.
Prior to GHO, he was a Vice President at HCI Equity Partners, a Washington, D.C. based private equity firm where his responsibilities included sourcing, transaction execution, financing and supporting management teams with the implementation of key growth initiatives. Brad started his career in investment banking at Cary Street Partners.
Brad is a graduate of the McIntire School of Commerce at the University of Virginia where he earned a B.S. degree in Commerce.
Cara joined GHO Capital in June 2016 after graduating from the London Metropolitan University with a first class honours degree in Criminology and Policing as well as receiving the 2016 award for academic excellence. Cara has additionally completed a legal secretary qualification at Regent's University.
Cara provides executive support to the Investment Team, and is in charge of office management and a wide range of administrative and executive support duties.
Job Titles:
- Managing Director, Investor Relations
Charles is an experienced investor relations, fundraising and corporate finance professional who brings a blend of relationship development and transaction execution skills.
Having joined GHO in 2017, he works closely with the investment, finance and legal teams at GHO as well as portfolio company management to lead fundraising, co-investment, reporting and investor coverage with Limited Partners as well as communications across all stakeholders.
Prior to GHO, Charles worked in the fundraising and investor relations team at 3i Group plc and was formerly in Rothschild & Co's M&A practice, splitting his time between the Energy & Power team in London and as a sector generalist in Moscow.
Charles holds a first class degree in Russian and History from the University of Edinburgh. A native English speaker, Charles is fluent in Russian and has lived and worked in the UK and Russia.
Charles is an investment professional with a background in corporate finance in the healthcare, consumer, and industrial sectors. Prior to GHO, he was with CapVest Partners where he evaluated mid-market investment opportunities in the consumer, healthcare and business services sectors. His responsibilities included deal sourcing, evaluation, and execution; alongside portfolio management where he took on the Interim Head of M&A role at a portfolio company to drive its buy-and-build strategy.
Charles started his career at Barclays Capital in London, where he gained a wealth of financing and transaction experience across M&A, LBOs, leveraged finance transactions and IPOs in the consumer and industrial sectors.
Charles graduated from the University of Warwick and holds a BSc in Economics, Politics, and International Studies. Charles is conversational in Mandarin, and has lived and worked in Singapore and the UK.
Charlie is an experienced investment professional with corporate finance experience, in Healthcare and Consumer.
Chris is an investment professional with a background in healthcare investment banking.
Chris joined the GHO team in 2019 and currently works closely with the Envision Pharma Group and X-Chem management teams, having previously also supported on Linimed.
Prior to GHO, he was with HSBC in London as part of their Healthcare team where he worked on a range of M&A, equity and debt transactions on behalf of both private equity and corporate clients across Europe and Asia.
Chris has a BSc in Mathematics with Economics from The London School of Economics and Political Science (LSE).
Claire is an investment professional with a background in M&A and financing advisory.
Having joined GHO in 2020, Claire currently works closely with the management teams at Ardena, Alcaliber and Linneo Health.
Prior to GHO, she was an Analyst in the Investment Banking division of J.P. Morgan in London, where she developed a broad range of financing and transactional experience working on mergers & acquisitions, capital markets operations and other strategic and financing solutions.
Claire graduated from EDHEC Business School and holds a Master in Management and a M.Sc. in Corporate Finance & Banking. A native French speaker, Claire is fluent in English and is conversational in German.
Cédric is an investment professional with a background in investment banking and corporate finance.
Prior to joining GHO in 2022, Cédric worked at Jefferies as part of their M&A team where he advised on multiple transactions in the healthcare, TMT and business services sectors. Cédric started his career at Ernst & Young's transaction advisory services department in Brussels.
Cédric has an M.Sc. in Business Economics with a major in Corporate Finance from Ghent University and an M.Sc. in Capital Markets, Regulation and Compliance from Henley Business School.
A native Dutch speaker, Cédric has lived and worked in the UK, Belgium and the Netherlands.
Darren is an experienced finance professional having performed a number of different finance and accounting roles in the financial services sector over the last 20 years.
Having joined GHO in 2018, Darren supports the CFO and has day to day management responsibility for corporate finance and various fund finance activities.
Prior to GHO, he was with Coller Capital where he held the positions of Management Accountant, Senior Commercial Accountant and latterly Group Financial Controller with management responsibility for the Group Finance team. Before Coller Capital, Darren worked at WestLB where he held roles including Commercial Manager and Financial Controller.
Darren graduated from Nottingham Trent University with a Bachelor's degree in Business Economics and is a Qualified Chartered Accountant.
David is a healthcare and private equity professional who combines a deep scientific understanding with his investment expertise.
Having joined GHO in 2017, David currently works with the management team at FairJourney Biologics, having previously supported on GHO's investment in Sterling Pharma Solutions.
David has over 6 years of clinical medicine experience across Australia and the United Kingdom, specialising in Anaesthetics and Trauma.
He holds an MBA with Distinction from London Business School, a Masters in Public Health from Australia's Newcastle University and a Bachelor of Medicine and Surgery with Honours from Monash University, Australia. He is a native English speaker and is conversational in French.
David is a 25 year veteran of the biopharmaceutical industry with executive and operational experience in the development and launch of over 20 products.
Previously, David was Senior Vice President of Global Market Access at Biogen with responsibility for securing patient access to Biogen products worldwide. Prior to Biogen, he founded a consultancy delivering business and commercial strategies for biopharmaceutical clients. He previously worked at Elan, as Vice President of Pharmacoeconomics, Managing Director, Asset Executive, and Head of International Operations. Dr. Miller began his career at GlaxoSmithKline, where he assumed increasing responsibilities toward becoming Vice President of Global Health Outcomes.
He served as a Director on the National Pharmaceutical Council Board of Directors, is a member of advisory boards at the University of Maryland Baltimore and University of Iowa, and is a board member of the Walther Foundation, a charitable organization supporting youth education. He served on the Board of Directors of Elan Pharma Ltd. and was Chair of the Board of Grants for the American Foundation for Pharmaceutical Education.
A dual US/UK citizen, he has lived and worked in markets in North America, Europe and Asia. Dr. Miller is the author or co-author of more than 70 scientific publications. He holds a degree in pharmacy from the University of Iowa and earned his Ph.D. at the University of Maryland Baltimore, where he studied health economics and policy.
Job Titles:
- Chartered Accountant
- Senior Management Accountant
Divya is a driven chartered accountant with over 8 years of experience in the financial services industry.
Having joined GHO in 2021, Divya works closely with the Director of Finance to manage all corporate finance aspects of the business including regulatory and tax reporting.
Prior to GHO, Divya was an Audit Manager within the Private Equity Group at KPMG in London, where she had responsibility for planning, execution, and management of a portfolio of Private Equity audit clients.
Divya has a Bachelor of Commerce (Honours) degree from University of Delhi in addition to her ACA qualification.
Job Titles:
- Partner
- Private Equity Executive
Edward is an experienced private equity executive with over 25 years of financial and principal investing experience focused on the European and North American mid-market.
Gareth is an investment professional with a background in corporate finance and accounting.
Prior to GHO, he was with OMERS Private Equity and responsible for sourcing, evaluating and executing deals in healthcare, business services and software; also working closely with management teams across the portfolio.
Gareth started his financial services career with Grant Thornton and Deloitte before moving to Rothschild & Co to advise on multiple M&A transactions in the consumer sector. He previously served as an Officer in the Royal Marines where he undertook a variety of leadership and training roles, including leading teams of up to 35 Commandos on active operations.
Gareth has a BEng in Mechanical Engineering from the University of Nottingham and is a Chartered Accountant.
Job Titles:
- Chairman
- Operating Partner
Geoffrey Hamilton-Fairley is an experienced Chairman, NED and investment advisor with a track record of leading companies at different stages of development from start-ups through to sale and IPO.
His entrepreneurial career started in 1982, founding a number of companies in Public Relations, Technology, Advertising and Music & Personality management backed by The Abingdon Management Company Limited, where he subsequently became sole owner having acquired Abingdon from its institutional shareholders. Abingdon had a number of quoted and unquoted investments including a Unit Trust, Foretronic (a technology company that introduced the magnetic data strip on the back of credit cards), TVS (ITV franchise for the South of England), and a significant property portfolio in the UK and abroad.
Returning to his medical roots, Geoffrey developed and guided Oncimmune, a company pioneering technologies to enable early cancer detection, from a Nottingham University start-up through to a successful IPO in May 2016, with total funds raised of £62m. During this period he co-authored numerous scientific and health economic publications.
He now acts as an advisor to leading technology and healthcare funds, advising investment teams, specific due diligence projects, monitoring investments as a director and mentoring CEOs.
Gilly joined GHO Capital in August 2021 having previously worked for an Ultra High Net Worth Property Developer in Central London. Gilly has a degree in Sociology from the University of Exeter.
Gilly provides executive support to the Legal Counsel, CFO, Finance team and a number of Investment team members.
Guy has over 30 years experience in identifying, analyzing, managing and exiting private equity transactions in the US, Europe and other geographies.
Previously, Guy was Partner and Investment Committee Member of the private equity group at NovaQuest Capital Management, LLC., a healthcare focused investment firm. His responsibilities included identifying, analyzing and managing control-oriented healthcare transactions and managing the private equity group and related funds.
Prior to NovaQuest, Guy was Partner and Investment Committee Member of Silverfleet Capital, a London headquartered private equity firm focused on control-oriented investments across Europe, the US and other geographies in the healthcare and other industries. Guy's responsibilities included transaction and portfolio company management activities and investment policy oversight. He was responsible for the firm's US effort, in addition to working with the firm's European offices on their investment activities. Guy was also Partner and Investment Committee Member of PPM America Capital Partners, the US based private equity group of Prudential, plc. Earlier in his career, Guy held positions with several middle market lenders including GE Capital.
Guy has served as a director on portfolio company boards and as an advisory board member for a private equity firm. He received an MBA from DePaul University and a BA in Business Administration from Illinois Wesleyan University.
Job Titles:
- Chartered Accountant
- Senior Fund Accountant
James is a driven chartered accountant with over 6 years of experience in the financial services industry.
Having joined GHO in 2019, James works closely with GHOs administrators, tax advisors and other service providers, with a focus on fund accounting and portfolio management.
Prior to joining GHO, James was an Audit Manager at Deloitte in the Channel Islands, where he had a responsibility for overseeing and directing the planning, co-ordination and control of a portfolio of large audit clients, primarily based in the Private Equity and Real Estate sector groups.
James graduated from Warwick University with a Bachelor's degree in Mathematics and Physics.
Jo has nearly a decade of experience as an Executive Assistant.
Prior to GHO Capital, Jo spent 8 years working for an Ultra High Net Worth Property Developer in central London. Jo has a degree in History of Art in addition to a Quest Secretarial College qualification.
Jo provides executive support to the Partners and Investment Team.
Job Titles:
- Partner
- Member of the Board at Sanner
Ken is a private equity investment professional who brings a wealth of origination, M&A execution and management expertise.
Having joined GHO in 2016, Ken is currently a member of the board at Sanner, Linimed, Alcaliber and Linneo Health having previously also worked with Quotient Sciences.
Prior to GHO, he was with Stirling Square Capital Partners in London where he was responsible for mid-market pan-European buyouts. Before Stirling, Ken was a private equity investor with Odewald & Compagnie in Berlin working on German Mittelstand transactions, having started his career as a leveraged finance banker with Citigroup and Bank of America Securities in London and New York.
Ken has an MSc in Investment Management from Cass Business School and graduated from the University of Buckingham with a BSc in Business Economics. A native German speaker, with conversational Spanish, Ken has lived and worked in the UK, USA, Germany and Colombia.
Job Titles:
- Non - Executive Vice Chair and Founder
Lady Mireille founded and grew HUYABIO International to be the leader in accelerating the advancement of novel biopharmaceutical product opportunities originating in China enabling faster, more cost-effective, and lower-risk drug development in global markets. Through this model Hiyasta, an immuno-oncology drug that treats patients with cancer has been successfully launched in Japan. Lady Mireille was appointed to the Board of Quintiles, now IQVIA, a Fortune 500 company. Currently, she serves on the Pasteur Institute advisory board.
Mireille and Dennis realised the need for a European private equity fund specialising in global health opportunities and financially co-founded GHO Capital. They were the cornerstone investor for the inception of GHO. Among the many honors she has received, the French Government awarded Mireille its highest national award, the Knight of the Legion of Honor in recognition of her contributions to neuroscience and entrepreneurship. Lady Mireille was bestowed an Honorary Degree by the University of Exeter. She has also twice been named by the UK Sunday Times as one of the Top Female Entrepreneurs.
Laura is an experienced Financial Services professional, with over 9 years' experience within the industry.
Having joined the Finance Team at GHO in April 2019, Laura takes responsibility for day to day running of the Corporate Finance function, including management accounting, budgeting and all payments.
Prior to joining GHO, Laura was a Senior Client Service Executive at Rothschild Wealth Management, where she had responsibility for all aspects of client reporting. Laura has also held roles within both Finance and Client Relationship Management at London & Capital and Hermes GPE.
Laura graduated with a Bachelor's degree in Marketing and Management from the University of Newcastle. She has Passed Unit 1 of the Investment Management Certificate and is currently studying towards her ACA accountancy qualification with ICAEW.
Lauren is an experienced HR professional with a career of over fifteen years in Financial Services.
Prior to joining GHO, Lauren spent nine years at Perella Weinberg Partners as the Head of Human Resources (EMEA), where she was also a member of the board of the Perella Weinberg Partners Foundation.
Lauren previously worked at The Bank of New York Mellon and Citi and has experience across Investment Banking/Advisory, Fixed Income, Equities and Corporate Functions.
Throughout her career Lauren has been focused on improving Diversity in the Financial Services Sector. She is currently a member of the advisory board of Working Options in Education, an employability and life skills charity that aims to increase career pathway opportunities for young people aged fourteen to nineteen, prioritising those from the most under-served areas of the country.
Lauren has a BA in Business and is a Chartered Member of the Chartered Institute of Personnel and Development.
Leo is an investment professional with experience in strategy consulting, investment banking and private equity as well as on management teams and boards of directors.
Prior to GHO, Leo was Head of M&A and served on various committees at Advanz Pharma, a global specialty pharmaceuticals business headquartered in London, UK. Prior to that, he was in the investment team of G Square Healthcare Private Equity LLP, a private equity firm focused on buy-out and growth healthcare opportunities throughout Europe. His responsibilities at G Square included deal sourcing, evaluation, execution, and portfolio management through to the realisation of investments.
Leo began his career as a strategy consultant focused mainly on healthcare/education/tech sectors at Bainbridge in La Jolla, California, USA before moving over to investment banking: first in the Generalist M&A team at Lazard in Paris, France and then the Healthcare M&A team at N.M. Rothschild & Sons in London, UK.
Leo holds a BA in Economics from the University of California, San Diego and dual-MBA degrees from HEC Paris and Tsinghua University. Leo is a dual USA/UK citizen and has lived and worked in various cities across North America, Asia, UK and continental Europe.
Lorna has over 20 years experience in Financial Services, prior to her joining GHO as CFO in July 2017.
Lorna started her career in the Banking and Capital Markets division of PWC, gaining her ACA and then moving on to roles predominantly within Private Equity, but also spending some time in Investment Banking.
She spent 6 years at Terra Firma Capital Partners, covering all of Fund finance, Transaction support, Co investment and the firms operations in Guernsey and Luxembourg. Following Terra Firma, Lorna spent some years in the Restructuring division of RBS, heading the Finance team for both the Debt to Equity portfolio and the Restructuring division at Ulster Bank, Dublin, following the 2008 downturn. She then moved to Coller Capital, where she had responsibility for the Group Finance team as well as sitting on the Operating Committee and supporting the COO.
Her remit at GHO covers all of Fund Finance, Valuations, Transaction and tax structuring, Group Finance and all aspects of tax compliance.
Lorna has a BA in English Literature in addition to her ACA qualification.
Job Titles:
- Director of Sustainable Investing
Manuela is an investment professional with a background in healthcare M&A and capital raising across the PharmaBio, MedTech, Patient Services and Outsourced Services sub-sectors.
Having joined GHO in 2014, Manuela currently works closely with the VISUfarma management team, having previously also supported on GHO's investment in Quotient Sciences.
Prior to GHO, she was a healthcare investment banker at Barclays Capital in London, where she started her career and gained a wealth of financing and transaction experience across sale processes, mergers, LBOs, leveraged finance transactions and IPOs.
Manuela holds an MSc in Finance cum laude from Bocconi University and graduated with a BSc in Economics and Management from Bocconi University and Ross Business School, University of Michigan. A native Italian, speaking conversational Spanish, Manuela has lived and worked in the UK, USA and Italy.
Job Titles:
- Associate, Investor Relations
Job Titles:
- Non - Executive Chair and Founder